Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04783246 · ClinicalTrials.gov registry record · NA

Virtual Group Fitness and Nutrition Intervention for Individuals With Psychosis

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT04783246: Completed NA study, sponsored by Boston Medical Center.

NCT04783246 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04783246, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Individuals with schizophrenia spectrum disorder (SSD) often face unique barriers that limit the development of long-lasting lifestyle changes. In this study, The investigators will investigate the feasibility and impact of a novel lifestyle intervention in individuals with schizophrenia or schizoaffective disorder. The intervention will be composed of group fitness instruction and educational nutrition didactics that will be accessible to participants at-home through remote streaming. The fitness component will consist of weekly group fitness sessions delivered by a certified personal trainer over a virtual interface. The educational nutritional component of this intervention will involve interactive didactic sessions designed to improve knowledge of nutrition and positively change dietary behavior in this population.

Primary Outcome

Feasibility of the lifestyle intervention will be assessed by the satisfaction level of participants which will be obtained from questions on an investigator developed questionnaire. Higher satisfaction levels will suggest greater feasibility.

Interventions

  • BEHAVIORAL Group Fitness
  • OTHER Nutrition education

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2021-10-26
Est. Completion 2023-07-24
Phase NA
Boston Medical Center

253 total trials

What the finished NCT04783246 record still lists

NCT04783246 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Group Fitness is the first listed.

NCT04783246 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04783246 about?

NCT04783246 is a clinical study titled "Virtual Group Fitness and Nutrition Intervention for Individuals With Psychosis". Individuals with schizophrenia spectrum disorder (SSD) often face unique barriers that limit the development of long-lasting lifestyle changes. In this study, The investigators will investigate the feasibility and impact of a novel lifestyle intervention in individuals with schizophrenia or schizoaf...

What is the current status of trial NCT04783246?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-10-26. Estimated completion is 2023-07-24.

What interventions are being tested in trial NCT04783246?

The interventions under investigation include: Group Fitness (BEHAVIORAL), Nutrition education (OTHER).

Who is sponsoring clinical trial NCT04783246?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04783246's enrollment target sits among peer trials

21 1762nd of 2000 higher than 233 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04783246, the US trial registry maintained by the National Library of Medicine. NCT04783246 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.